Compare LEXX & YHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LEXX | YHC |
|---|---|---|
| Founded | 2004 | 2021 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Beverages (Production/Distribution) |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 18.9M | 21.0M |
| IPO Year | N/A | N/A |
| Metric | LEXX | YHC |
|---|---|---|
| Price | $0.65 | $0.88 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $1.50 | N/A |
| AVG Volume (30 Days) | ★ 173.0K | 108.2K |
| Earning Date | 04-14-2026 | 11-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $522,000.00 | ★ $2,103,341.00 |
| Revenue This Year | $13.35 | $69.97 |
| Revenue Next Year | $78.83 | $403.29 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 5.05 | N/A |
| 52 Week Low | $0.46 | $0.68 |
| 52 Week High | $1.90 | $98.00 |
| Indicator | LEXX | YHC |
|---|---|---|
| Relative Strength Index (RSI) | 42.42 | 47.85 |
| Support Level | $0.67 | $0.84 |
| Resistance Level | $0.79 | $0.95 |
| Average True Range (ATR) | 0.07 | 0.06 |
| MACD | -0.01 | 0.00 |
| Stochastic Oscillator | 28.97 | 58.36 |
Lexaria Bioscience Corp is a biotechnology company focused on enhancing the bioavailability of active pharmaceutical ingredients using its patented DehydraTECH drug delivery technology. DehydraTECH improves absorption, effectiveness, and tolerability and can be applied to APIs such as GLP-1 and GIP drugs, vitamins, pain medications, hormones, antivirals, nicotine and cannabinoids across therapeutic areas including diabetes, weight loss, epilepsy, hypertension, and heart disease. It can be used in formats such as tablets, capsules, oral suspensions, foods, beverages, and pouches, and supports pharmaceuticals, nutraceuticals, over-the-counter products, and consumer packaged goods. The Company operates one segment: IP licensing, generating revenue from licensing its DehydraTECH technology.
LQR House Inc intends to become the full-service digital marketing and brand development face of the alcoholic beverage space. It also intends to integrate the supply, sales, and marketing facets of the alcoholic beverage space into one easy-to-use platform and become the one-stop shop for everything related to alcohol. The company's primary business includes the development of premium limited-batch spirit brands, establishing an exclusive wine club, and marketing internal and external brands through an exclusive agreement with a United States-based e-commerce portal. It believes that the marketing and brand management services it provides to its wholly owned and third-party clients will increase brand recognition, and drive sales thereof through its e-commerce platform partner.